86 related articles for article (PubMed ID: 12119549)
1. Keratinocyte injury in drug-induced toxic epidermal necrolysis: Simultaneous but distinct topographic expression of CD95R and calprotectin.
Paquet P; Piérard GE
Int J Mol Med; 2002 Aug; 10(2):145-7. PubMed ID: 12119549
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced toxic epidermal necrolysis and pancytopenia: a puzzling association.
Paquet P; Jacob E; Pirson J; Pierard GE
Int J Mol Med; 2005 Jul; 16(1):29-33. PubMed ID: 15942674
[TBL] [Abstract][Full Text] [Related]
3. Analytical quantification of the inflammatory cell infiltrate and CD95R expression during treatment of drug-induced toxic epidermal necrolysis.
Paquet P; Jacob E; Damas P; Pirson J; Piérard G
Arch Dermatol Res; 2005 Dec; 297(6):266-73. PubMed ID: 16249890
[TBL] [Abstract][Full Text] [Related]
4. Epidermal interleukin-8 and its receptor CXCR2 in drug-induced toxic epidermal necrolysis.
Paquet P; Ribbens C; Piérard GE
Clin Exp Dermatol; 2007 Nov; 32(6):728-32. PubMed ID: 17714530
[TBL] [Abstract][Full Text] [Related]
5. Differential pathomechanisms of epidermal necrolytic blistering diseases.
Paquet P; Piérard GE
Int J Mol Med; 2002 Dec; 10(6):695-9. PubMed ID: 12429994
[TBL] [Abstract][Full Text] [Related]
6. Glutathione-S-transferase pi expression in toxic epidermal necrolysis: a marker of putative oxidative stress in keratinocytes.
Paquet P; Piérard GE
Skin Pharmacol Physiol; 2007; 20(2):66-70. PubMed ID: 17139195
[TBL] [Abstract][Full Text] [Related]
7. Novel treatments for drug-induced toxic epidermal necrolysis (Lyell's syndrome).
Paquet P; Piérard GE; Quatresooz P
Int Arch Allergy Immunol; 2005 Mar; 136(3):205-16. PubMed ID: 15713983
[TBL] [Abstract][Full Text] [Related]
8. Toxic epidermal necrolysis: revisiting the tentative link between early apoptosis and late necrosis (review).
Paquet P; Pierard GE
Int J Mol Med; 2007 Jan; 19(1):3-10. PubMed ID: 17143541
[TBL] [Abstract][Full Text] [Related]
9. Regulation of calprotectin expression by interleukin-1alpha and transforming growth factor-beta in human gingival keratinocytes.
Hayashi N; Kido J; Kido R; Wada C; Kataoka M; Shinohara Y; Nagata T
J Periodontal Res; 2007 Feb; 42(1):1-7. PubMed ID: 17214633
[TBL] [Abstract][Full Text] [Related]
10. Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding.
French LE; Trent JT; Kerdel FA
Int Immunopharmacol; 2006 Apr; 6(4):543-9. PubMed ID: 16504917
[TBL] [Abstract][Full Text] [Related]
11. Skin immunoglobulin deposition following intravenous immunoglobulin therapy in toxic epidermal necrolysis.
Paquet P; Kaveri S; Jacob E; Pirson J; Quatresooz P; Piérard GE
Exp Dermatol; 2006 May; 15(5):381-6. PubMed ID: 16630079
[TBL] [Abstract][Full Text] [Related]
12. Epidermal calprotectin in drug-induced toxic epidermal necrolysis.
Paquet P; Piérard GE
J Cutan Pathol; 1999 Jul; 26(6):301-5. PubMed ID: 10472759
[TBL] [Abstract][Full Text] [Related]
13. Facing up to toxic epidermal necrolysis.
Piérard GE; Paquet P
Expert Opin Pharmacother; 2010 Oct; 11(15):2443-6. PubMed ID: 20707598
[TBL] [Abstract][Full Text] [Related]
14. Functionally active macrophage-derived myeloperoxidase in the skin of drug-induced toxic epidermal necrolysis.
Paquet P; De Groote D; Piérard GE
Dermatology; 2010; 220(3):201-7. PubMed ID: 20332596
[TBL] [Abstract][Full Text] [Related]
15. Effect of N-acetylcysteine combined with infliximab on toxic epidermal necrolysis. A proof-of-concept study.
Paquet P; Jennes S; Rousseau AF; Libon F; Delvenne P; Piérard GE
Burns; 2014 Dec; 40(8):1707-12. PubMed ID: 24726294
[TBL] [Abstract][Full Text] [Related]
16. Human epidermal basal cell responses to ultraviolet-B differ according to their location in the undulating epidermis.
Baba H; Yoshida M; Yokota T; Uchiwa H; Watanabe S
J Dermatol Sci; 2005 Apr; 38(1):41-6. PubMed ID: 15795122
[TBL] [Abstract][Full Text] [Related]
17. Variable Bax antigenicity is linked to keratinocyte position within epidermal strata and UV-induced apoptosis.
Zuliani T; Obriot H; Tual M; Lachman-Weber N; Dumas M; Formstecher P; Polakowska R; Ratinaud MH
Exp Dermatol; 2008 Feb; 17(2):125-32. PubMed ID: 18177350
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical evaluation of toxic epidermal necrolysis treated with human intravenous immunoglobulin.
Romanelli P; Schlam E; Green JB; Trent JT; Ricotti C; Elgart GW; Kirsner RS; Kerdel FA
G Ital Dermatol Venereol; 2008 Aug; 143(4):229-33. PubMed ID: 18833079
[TBL] [Abstract][Full Text] [Related]
19. Apoptolysis: a novel mechanism of skin blistering in pemphigus vulgaris linking the apoptotic pathways to basal cell shrinkage and suprabasal acantholysis.
Grando SA; Bystryn JC; Chernyavsky AI; Frusić-Zlotkin M; Gniadecki R; Lotti R; Milner Y; Pittelkow MR; Pincelli C
Exp Dermatol; 2009 Sep; 18(9):764-70. PubMed ID: 19555352
[TBL] [Abstract][Full Text] [Related]
20. Immunological mechanisms of epidermal damage in toxic epidermal necrolysis.
Tohyama M; Hashimoto K
Curr Opin Allergy Clin Immunol; 2012 Aug; 12(4):376-82. PubMed ID: 22688730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
